{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease", "Anti-arthritic", "Anti-bacterial", "Anti-cancer", "Anti-diabetic", "Anti-inflammatory", "Anti-stress", "Cardio-protective", "Parkinson\u2019s disease", "Stroke hypoxia", "Withania somnifera"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "26306935", "DateCompleted": {"Year": "2016", "Month": "04", "Day": "25"}, "DateRevised": {"Year": "2024", "Month": "05", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2015", "Month": "08", "Day": "26"}], "ELocationID": ["10.1007/s00018-015-2012-1"], "Language": ["eng"], "Journal": {"ISSN": "1420-9071", "JournalIssue": {"Volume": "72", "Issue": "23", "PubDate": {"Year": "2015", "Month": "Dec"}}, "Title": "Cellular and molecular life sciences : CMLS", "ISOAbbreviation": "Cell Mol Life Sci"}, "ArticleTitle": "Pharmacologic overview of Withania somnifera, the Indian Ginseng.", "Pagination": {"StartPage": "4445", "EndPage": "4460", "MedlinePgn": "4445-60"}, "Abstract": {"AbstractText": ["Withania somnifera, also called 'Indian ginseng', is an important medicinal plant of the Indian subcontinent. It is widely used, singly or in combination, with other herbs against many ailments in Indian Systems of Medicine since time immemorial. Withania somnifera contains a spectrum of diverse phytochemicals enabling it to have a broad range of biological implications. In preclinical studies, it has shown anti-microbial, anti-inflammatory, anti-tumor, anti-stress, neuroprotective, cardioprotective, and anti-diabetic properties. Additionally, it has demonstrated the ability to reduce reactive oxygen species, modulate mitochondrial function, regulate apoptosis, and reduce inflammation and enhance endothelial function. In view of these pharmacologic properties, W. somnifera is a potential drug candidate to treat various clinical conditions, particularly related to the nervous system. In this review, we summarize the pharmacologic characteristics and discuss the mechanisms of action and potential therapeutic applications of the plant and its active constituents."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Neuropharmacology Laboratory, Indian Institute of Integrative Medicine-CSIR, Sanat Nagar, Srinagar, 190005, India."}, {"Identifier": [], "Affiliation": "Cancer Pharmacology Division, Indian Institute of Integrative Medicine-CSIR, Canal Road, Jammu, 180001, India."}, {"Identifier": [], "Affiliation": "Academy of Scientific and Innovative Research (AcSIR), Indian Institute of Integrative Medicine-CSIR, Canal Road, Jammu, 180001, Jammu and Kashmir, India."}], "LastName": "Dar", "ForeName": "Nawab John", "Initials": "NJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Pharmacology Division, Indian Institute of Integrative Medicine-CSIR, Canal Road, Jammu, 180001, India."}, {"Identifier": [], "Affiliation": "Academy of Scientific and Innovative Research (AcSIR), Indian Institute of Integrative Medicine-CSIR, Canal Road, Jammu, 180001, Jammu and Kashmir, India."}], "LastName": "Hamid", "ForeName": "Abid", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Neuropharmacology Laboratory, Indian Institute of Integrative Medicine-CSIR, Sanat Nagar, Srinagar, 190005, India. mahmad@iiim.res.in."}, {"Identifier": [], "Affiliation": "Academy of Scientific and Innovative Research (AcSIR), Indian Institute of Integrative Medicine-CSIR, Canal Road, Jammu, 180001, Jammu and Kashmir, India. mahmad@iiim.res.in."}], "LastName": "Ahmad", "ForeName": "Muzamil", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Cell Mol Life Sci", "NlmUniqueID": "9705402", "ISSNLinking": "1420-682X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Infective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents, Non-Steroidal"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Cardiotonic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Withanolides"}, {"RegistryNumber": "L6DO3QW4K5", "NameOfSubstance": "withaferin A"}], "MeshHeadingList": [{"QualifierName": ["drug therapy"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Anti-Infective Agents"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Anti-Inflammatory Agents, Non-Steroidal"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Cardiotonic Agents"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "India"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Inflammation"}, {"QualifierName": [], "DescriptorName": "Medicine, Ayurvedic"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Parkinson Disease"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemistry"], "DescriptorName": "Withania"}, {"QualifierName": ["pharmacokinetics", "pharmacology", "toxicity"], "DescriptorName": "Withanolides"}], "CoiStatement": "Authors do not have any conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Dhuley JN. Effect of ashwagandha on lipid peroxidation in stress-induced animals. J Ethnopharmacol. 1998;60:173\u2013178. doi: 10.1016/S0378-8741(97)00151-7.", "ArticleIdList": ["10.1016/S0378-8741(97)00151-7", "9582008"]}, {"Citation": "Ziauddin M, Phansalkar N, Patki P, Diwanay S, Patwardhan B. Studies on the immunomodulatory effects of Ashwagandha . J Ethnopharmacol. 1996;50:69\u201376. doi: 10.1016/0378-8741(95)01318-0.", "ArticleIdList": ["10.1016/0378-8741(95)01318-0", "8866726"]}, {"Citation": "Hepper FN. Old World Withania (Solanaceae): a taxonomic review and key to the species. In: Hawkes JG, Lester RN, Nee M, Estrada N, editors. Solanaceae III: taxonomy, chemistry, evolution. London: Royal Botanic Gardens Kew and Linnean Society of London; 1991."}, {"Citation": "Purdie RW, Symon DE, Haegi L. Solanaceae. Flora Aust. 1982;29:184."}, {"Citation": "Van Wyk B-E, Wink M. Medicinal plants of the world. Pretoria: Briza Publications; 2004."}, {"Citation": "Uddin Q, Samiulla L, Singh V, Jamil S. Phytochemical and pharmacological profile of Withania somnifera dunal: a review. J Appl Pharm Sci. 2012;02(01):170\u2013175."}, {"Citation": "Singh N, Bhalla M, de Jager P, Gilca M. An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda. Afr J Tradit Complement Altern Med. 2011;8(S):208\u2013213.", "ArticleIdList": ["PMC3252722", "22754076"]}, {"Citation": "Changhadi GS. Ashwagandharishta\u2014Rastantra Sar Evam Sidhyaprayog Sangrah. Nagpur: Krishna-Gopal Ayurveda Bhawan (Dharmarth Trust); 1938. pp. 743\u2013774."}, {"Citation": "Sharma PV. Ashwagandha. Chaukhambha Viashwabharti Varanasi: Dravyaguna Vijana; 1999. pp. 763\u2013765."}, {"Citation": "Bhandari CR (1970) Ashwagandha (Withania somnifera) Vanaushadhi Chandroday (An Encyclopedia of Indian Herbs), vol 1. CS Series, Varanasi Vidyavilas Press, Varanasi, India, pp 96\u201397"}, {"Citation": "Basu KA. Withania somnifera, Indian medicinal plants. 2. Allahabad: IIIrd Lalit Mohan Basu; 1935. pp. 1774\u20131776."}, {"Citation": "Mishra B. Ashwagandha\u2014Bhavprakash Nigantu (Indian Materia Medica) Chaukhambha Bharti Academy: Varanasi; 2004. pp. 393\u2013394."}, {"Citation": "Sharma S, Dahanukar S, Karandikar S. Effects of long-term administration of the roots of ashwagandha and shatavari in rats. Indian Drugs. 1985;22:133."}, {"Citation": "Machiah DK, Girish K, Gowda TV. A glycoprotein from a folk medicinal plant, Withania somnifera, inhibits hyaluronidase activity of snake venoms. Comp Biochem Physiol C Toxicol Pharmacol. 2006;143:158\u2013161. doi: 10.1016/j.cbpc.2006.01.006.", "ArticleIdList": ["10.1016/j.cbpc.2006.01.006", "16513428"]}, {"Citation": "Machiah DK, Gowda TV. Purification of a post-synaptic neurotoxic phospholipase A 2 from Naja naja venom and its inhibition by a glycoprotein from Withania somnifera . Biochimie. 2006;88:701\u2013710. doi: 10.1016/j.biochi.2005.12.006.", "ArticleIdList": ["10.1016/j.biochi.2005.12.006", "16494989"]}, {"Citation": "Agarwal R, Diwanay S, Patki P, Patwardhan B. Studies on immunomodulatory activity of Withania somnifera (Ashwagandha) extracts in experimental immune inflammation. J Ethnopharmacol. 1999;67:27\u201335. doi: 10.1016/S0378-8741(99)00065-3.", "ArticleIdList": ["10.1016/S0378-8741(99)00065-3", "10616957"]}, {"Citation": "Ali M, Shuaib M, Ansari SH. Withanolides from the stem bark of Withania somnifera . Phytochemistry. 1997;44:1163\u20131168. doi: 10.1016/S0031-9422(96)00656-5.", "ArticleIdList": ["10.1016/S0031-9422(96)00656-5"]}, {"Citation": "Ghani N (1920) Khazain-ul-Adviyah, vol I. Munshi Nawal Kishore, Lucknow, pp 230\u2013231"}, {"Citation": "Kabiruddin M. Makhzan-ul-Mufradat. Lahore: Nadeem University Printers; 1955. pp. 75\u201376."}, {"Citation": "Nadkarni KM (1982) Indian Materia Medica, 3rd edn, vol I. Popular Prakashan Pvt Ltd, Bombay, pp 1292\u20131294"}, {"Citation": "Tiwari R, Chakraborty S, Saminathan M, Dhama K, Singh SV. Ashwagandha (Withania somnifera): role in safeguarding health, immunomodulatory effects, combating infections and therapeutic applications: a review. J Biol Sci. 2014;14(2):77\u201394. doi: 10.3923/jbs.2014.77.94.", "ArticleIdList": ["10.3923/jbs.2014.77.94"]}, {"Citation": "Ven Murthy M, Ranjekar PK, Ramassamy C, Deshpande M. Scientific basis for the use of Indian Ayurvedic medicinal plants in the treatment of neurodegenerative disorders: 1. Ashwagandha. Cent Nerv Syst Agents Med Chem. 2010;10:238\u2013246. doi: 10.2174/1871524911006030238.", "ArticleIdList": ["10.2174/1871524911006030238", "20528765"]}, {"Citation": "Seenivasagam R, Sathiyamoorthy S, Hemavathi K. Therapeutic impacts of Indian and Korean ginseng on human beings\u2014a review. Int J Immunol Stud. 2011;1:297\u2013317. doi: 10.1504/IJIS.2011.041727.", "ArticleIdList": ["10.1504/IJIS.2011.041727"]}, {"Citation": "Grandhi A, Mujumdar AM, Patwardhan B. A comparative pharmacological investigation of Ashwagandha and Ginseng. J Ethnopharmacol. 1994;44:131\u2013135. doi: 10.1016/0378-8741(94)01119-2.", "ArticleIdList": ["10.1016/0378-8741(94)01119-2", "7898119"]}, {"Citation": "Kaur K, Rani G, Widodo N, Nagpal A, Taira K, et al. Evaluation of the anti-proliferative and anti-oxidative activities of leaf extract from in vivo and in vitro raised Ashwagandha. Food Chem Toxicol. 2004;42:2015\u20132020. doi: 10.1016/j.fct.2004.07.015.", "ArticleIdList": ["10.1016/j.fct.2004.07.015", "15500938"]}, {"Citation": "Chopra A, Lavin P, Patwardhan B, Chitre D. A 32-week randomized, placebo-controlled clinical evaluation of RA-11, an Ayurvedic drug, on osteoarthritis of the knees. JCR J Clin Rheumatol. 2004;10:236\u2013245. doi: 10.1097/01.rhu.0000138087.47382.6d.", "ArticleIdList": ["10.1097/01.rhu.0000138087.47382.6d", "17043520"]}, {"Citation": "Mirjalili MH, Moyano E, Bonfill M, Cusido RM, Palazon J. Steroidal lactones from Withania somnifera, an ancient plant for novel medicine. Molecules. 2009;14:2373\u20132393. doi: 10.3390/molecules14072373.", "ArticleIdList": ["10.3390/molecules14072373", "PMC6255378", "19633611"]}, {"Citation": "Mishra LC, Singh BB, Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Med Rev. 2000;5:334\u2013346.", "ArticleIdList": ["10956379"]}, {"Citation": "Matsuda H, Murakami T, Kishi A, Yoshikawa M. Structures of withanolides I, II, III, IV, V, VI, and VII, new withanolide glycosides, from the roots of Indian Withania somnifera DUNAL and inhibitory activity for tachyphylaxis to clonidine in isolated guinea-pig ileum. Bioorg Med Chem. 2001;9:1499\u20131507. doi: 10.1016/S0968-0896(01)00024-4.", "ArticleIdList": ["10.1016/S0968-0896(01)00024-4", "11408168"]}, {"Citation": "Singh G, Sharma P, Dudhe R, Singh S. Biological activities of Withania somnifera . Ann Biol Res. 2010;1:56\u201363."}, {"Citation": "Bhattacharya SK, Goel RK, Kaur R, Ghosal S. Anti-stress activity of sitoindosides VII and VIII, new acylsterylglucosides from Withania somnifera . Phytother Res. 1987;1:32\u201337. doi: 10.1002/ptr.2650010108.", "ArticleIdList": ["10.1002/ptr.2650010108"]}, {"Citation": "Ghosal S, Kaur R, Srivastava R. Sito-indosides IX and X, two new glycowithanolides from Withania somnifera . Indian J Nat Prod. 1988;4:12\u201313."}, {"Citation": "Majumdar D. Withania somnifera Dunal, Part II. Alkaloidal constituents and their chemical characterization. Indian J Pharm. 1955;17:158\u2013161."}, {"Citation": "Praveen N, Murthy H. Production of withanolide-A from adventitious root cultures of Withania somnifera . Acta Physiol Plant. 2010;32:1017\u20131022. doi: 10.1007/s11738-010-0489-7.", "ArticleIdList": ["10.1007/s11738-010-0489-7"]}, {"Citation": "Misra L, Mishra P, Pandey A, Sangwan RS, Sangwan NS, et al. Withanolides from Withania somnifera roots. Phytochemistry. 2008;69:1000\u20131004. doi: 10.1016/j.phytochem.2007.10.024.", "ArticleIdList": ["10.1016/j.phytochem.2007.10.024", "18061221"]}, {"Citation": "Subbaraju GV, Vanisree M, Rao CV, Sivaramakrishna C, Sridhar P, et al. Ashwagandhanolide, a bioactive dimeric thiowithanolide isolated from the roots of Withania somnifera\u22a5. J Nat Prod. 2006;69:1790\u20131792. doi: 10.1021/np060147p.", "ArticleIdList": ["10.1021/np060147p", "17190461"]}, {"Citation": "Anjaneyulu A, Rao D, Lequesne P. Withanolides, biologically active natural steroidal lactones. Struct Chem Part F. 1998;20:135. doi: 10.1016/S1572-5995(97)80032-4.", "ArticleIdList": ["10.1016/S1572-5995(97)80032-4"]}, {"Citation": "Kirson I, Glotter E, Abraham A, Lavie D. Constituents of Withania somnifera dun\u2014XI: the structure of three new withanolides. Tetrahedron. 1970;26:2209\u20132219. doi: 10.1016/S0040-4020(01)92800-5.", "ArticleIdList": ["10.1016/S0040-4020(01)92800-5"]}, {"Citation": "Lavie D, Glotter E, Shvo Y. Constituents of Withania somnifera Dun. III. The side chain of withaferin A*, 1. J Org Chem. 1965;30:1774\u20131778. doi: 10.1021/jo01017a015.", "ArticleIdList": ["10.1021/jo01017a015"]}, {"Citation": "Lavie D, Kashman Y, Glotter E. Constituents of Withania somnifera dun\u2014V: studies on some model steroidal epoxides. Tetrahedron. 1966;22:1103\u20131111. doi: 10.1016/0040-4020(66)80086-8.", "ArticleIdList": ["10.1016/0040-4020(66)80086-8"]}, {"Citation": "Glotter E, Abraham A, G\u00fcnzberg G, Kirson I. Naturally occurring steroidal lactones with a 17\u03b1-oriented side chain. Structure of withanolide E and related compounds. J Chem Soc Perkin. 1977;1:341\u2013346. doi: 10.1039/p19770000341.", "ArticleIdList": ["10.1039/p19770000341"]}, {"Citation": "Kirson I, Glotter E, Lavie D, Abraham A (1971) Constituents of Withania somnifera Dun: part XII. The withanolides of an Indian chemotype. J Chem Soc 2032\u20132044"}, {"Citation": "Dhalla N, Sastry M, Malhotra C. Chemical studies of the leaves of Withania somnifera . J Pharm Sci. 1961;50:876\u2013877. doi: 10.1002/jps.2600501019.", "ArticleIdList": ["10.1002/jps.2600501019", "13885950"]}, {"Citation": "Pramanick S, Roy A, Ghosh S, Majumder HK, Mukhopadhyay S. Withanolide Z, a new chlorinated withanolide from Withania somnifera . Planta Med. 2008;74:1745\u20131748. doi: 10.1055/s-2008-1081357.", "ArticleIdList": ["10.1055/s-2008-1081357", "18988152"]}, {"Citation": "Jayaprakasam B, Zhang Y, Seeram NP, Nair MG. Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves. Life Sci. 2003;74:125\u2013132. doi: 10.1016/j.lfs.2003.07.007.", "ArticleIdList": ["10.1016/j.lfs.2003.07.007", "14575818"]}, {"Citation": "Jayaprakasam B, Nair MG. Cyclooxygenase-2 enzyme inhibitory withanolides from Withania somnifera leaves. Tetrahedron. 2003;59:841\u2013849. doi: 10.1016/S0040-4020(02)01601-0.", "ArticleIdList": ["10.1016/S0040-4020(02)01601-0"]}, {"Citation": "Menssen H, Stapel G (1973) Uber ein C28-Steroidlacton aus der Wurzel von Withania Somnifera. Plant Med", "ArticleIdList": ["4779643"]}, {"Citation": "Abou-Douh AM. New withanolides and other constituents from the fruit of Withania somnifera . Arch Pharm. 2002;335(6):267\u2013276. doi: 10.1002/1521-4184(200208)335:6<267::AID-ARDP267>3.0.CO;2-E.", "ArticleIdList": ["10.1002/1521-4184(200208)335:6<267::AID-ARDP267>3.0.CO;2-E", "12210769"]}, {"Citation": "Kundu AB, Mukherjee A, Dey A. New Withanolide from seeds of Withania-somnifera dunal. Indian J Chem. 1976;14:434\u2013435."}, {"Citation": "Jayaprakasam B, Strasburg GA, Nair MG. Potent lipid peroxidation inhibitors from Withania somnifera fruits. Tetrahedron. 2004;60:3109\u20133121. doi: 10.1016/j.tet.2004.01.016.", "ArticleIdList": ["10.1016/j.tet.2004.01.016"]}, {"Citation": "Xu Y-M, Marron MT, Seddon E, McLaughlin SP, Ray DT, et al. 2, 3-Dihydrowithaferin A-3\u03b2-O-sulfate, a new potential prodrug of withaferin A from aeroponically grown Withania somnifera . Bioorg Med Chem. 2009;17:2210\u20132214. doi: 10.1016/j.bmc.2008.10.091.", "ArticleIdList": ["10.1016/j.bmc.2008.10.091", "19056281"]}, {"Citation": "Khan F, Saeed M, Alam M, Chaudhry A. Biological studies of indigenous medicinal plants III. Phytochemical and antimicrobial studies on the non-alkaloidal constituents of some solanaceous fruits. Eczacilik Fakultesi Dergisi-Gazi Universitesi. 1993;10:105."}, {"Citation": "Prabu PC, Panchapakesan S, Raj CD. Acute and sub-acute oral toxicity assessment of the hydroalcoholic extract of Withania somnifera roots in Wistar rats. Phytother Res. 2013;27:1169\u20131178. doi: 10.1002/ptr.4854.", "ArticleIdList": ["10.1002/ptr.4854", "22996349"]}, {"Citation": "Prabu PC, Panchapakesan S. Prenatal developmental toxicity evaluation of Withania somnifera root extract in Wistar rats. Drug Chem Toxicol. 2015;38:50\u201356. doi: 10.3109/01480545.2014.900073.", "ArticleIdList": ["10.3109/01480545.2014.900073", "24649920"]}, {"Citation": "Sharada A, Solomon FE, Devi PU. Toxicity of Withania somnifera root extract in rats and mice. Pharm Biol. 1993;31:205\u2013212. doi: 10.3109/13880209309082943.", "ArticleIdList": ["10.3109/13880209309082943"]}, {"Citation": "Patil D, Gautam M, Mishra S, Karupothula S, Gairola S, et al. Determination of withaferin A and withanolide A in mice plasma using high-performance liquid chromatography-tandem mass spectrometry: application to pharmacokinetics after oral administration of Withania somnifera aqueous extract. J Pharm Biomed Anal. 2013;80:203\u2013212. doi: 10.1016/j.jpba.2013.03.001.", "ArticleIdList": ["10.1016/j.jpba.2013.03.001", "23584079"]}, {"Citation": "Thaiparambil JT, Bender L, Ganesh T, Kline E, Patel P, et al. Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation. Int J Cancer. 2011;129:2744\u20132755. doi: 10.1002/ijc.25938.", "ArticleIdList": ["10.1002/ijc.25938", "21538350"]}, {"Citation": "Dahikar PR, Kumar N, Sahni Y. Pharmacokinetics of Withania somnifera (ashwagandha) in healthy buffalo calves. Buffalo Bull. 2012;31:219."}, {"Citation": "Sumanth M, Nedunuri S. Comparison of bioavailability and bioequivalence of herbal anxiolytic drugs with marketed drug alprazolam. World J Pharm Res. 2014;3:1358\u20131366."}, {"Citation": "Bisht P, Rawat V. Antibacterial activity of Withania somnifera against Gram-positive isolates from pus samples. Ayu. 2014;35:330. doi: 10.4103/0974-8520.153757.", "ArticleIdList": ["10.4103/0974-8520.153757", "PMC4427836", "25972723"]}, {"Citation": "Singh G, Kumar P. Evaluation of antimicrobial efficacy of flavonoids of Withania somnifera L. Indian J Pharm Sci. 2011;73:473. doi: 10.4103/0250-474X.99019.", "ArticleIdList": ["10.4103/0250-474X.99019", "PMC3374571", "22707839"]}, {"Citation": "Alam N, Hossain M, Mottalib MA, Sulaiman SA, Gan SH, et al. Methanolic extracts of Withania somnifera leaves, fruits and roots possess antioxidant properties and antibacterial activities. BMC Complement Altern Med. 2012;12:175. doi: 10.1186/1472-6882-12-175.", "ArticleIdList": ["10.1186/1472-6882-12-175", "PMC3527235", "23039061"]}, {"Citation": "Mwitari PG, Ayeka PA, Ondicho J, Matu EN, Bii CC. Antimicrobial activity and probable mechanisms of action of medicinal plants of Kenya: Withania somnifera, Warbugia ugandensis, Prunus africana and Plectrunthus barbatus . PLoS One. 2013;8(6):e65619. doi: 10.1371/journal.pone.0065619.", "ArticleIdList": ["10.1371/journal.pone.0065619", "PMC3681961", "23785437"]}, {"Citation": "Owais M, Sharad K, Shehbaz A, Saleemuddin M. Antibacterial efficacy of Withania somnifera (ashwagandha) an indigenous medicinal plant against experimental murine salmonellosis. Phytomedicine. 2005;12:229\u2013235. doi: 10.1016/j.phymed.2003.07.012.", "ArticleIdList": ["10.1016/j.phymed.2003.07.012", "15830846"]}, {"Citation": "Arora S, Dhillon S, Rani G, Nagpal A. The in vitro antibacterial/synergistic activities of Withania somnifera extracts. Fitoterapia. 2004;75:385\u2013388. doi: 10.1016/j.fitote.2004.01.002.", "ArticleIdList": ["10.1016/j.fitote.2004.01.002", "15159002"]}, {"Citation": "Pandit S, Chang K-W, Jeon J-G. Effects of Withania somnifera on the growth and virulence properties of Streptococcus mutans and Streptococcus sobrinus at sub-MIC levels. Anaerobe. 2013;19:1\u20138. doi: 10.1016/j.anaerobe.2012.10.007.", "ArticleIdList": ["10.1016/j.anaerobe.2012.10.007", "23142795"]}, {"Citation": "Chandrasekaran S, Dayakar A, Veronica J, Sundar S, Maurya R. An in vitro study of apoptotic like death in Leishmania donovani promastigotes by withanolides. Parasitol Int. 2013;62:253\u2013261. doi: 10.1016/j.parint.2013.01.007.", "ArticleIdList": ["10.1016/j.parint.2013.01.007", "23416156"]}, {"Citation": "Grover A, Katiyar SP, Jeyakanthan J, Dubey VK, Sundar D. Blocking Protein kinase C signaling pathway: mechanistic insights into the anti-leishmanial activity of prospective herbal drugs from Withania somnifera . BMC Genom. 2012;13:S20. doi: 10.1186/1471-2164-13-S8-S20.", "ArticleIdList": ["10.1186/1471-2164-13-S8-S20", "PMC3521472", "23281834"]}, {"Citation": "El-On J, Ozer L, Gopas J, Sneir R, Enav H, et al. Antileishmanial activity in Israeli plants. Ann Trop Med Parasitol. 2009;103:297\u2013306. doi: 10.1179/136485909X440827.", "ArticleIdList": ["10.1179/136485909X440827", "19508747"]}, {"Citation": "Sachdeva H, Sehgal R, Kaur S. Studies on the protective and immunomodulatory efficacy of Withania somnifera along with cisplatin against experimental visceral leishmaniasis. Parasitol Res. 2013;112:2269\u20132280. doi: 10.1007/s00436-013-3387-2.", "ArticleIdList": ["10.1007/s00436-013-3387-2", "23519426"]}, {"Citation": "Dikasso D, Makonnen E, Debella A, Abebe D, Urga K, et al. Anti-malarial activity of Withania somnifera L. Dunal extracts in mice. Ethiop Med J. 2006;44:279\u2013285.", "ArticleIdList": ["17447395"]}, {"Citation": "Muregi FW, Ishih A, Suzuki T, Kino H, Amano T, et al. In Vivo antimalarial activity of aqueous extracts from Kenyan medicinal plants and their Chloroquine (CQ) potentiation effects against a blood-induced CQ-resistant rodent parasite in mice. Phytother Res. 2007;21:337\u2013343. doi: 10.1002/ptr.2067.", "ArticleIdList": ["10.1002/ptr.2067", "17221829"]}, {"Citation": "Girish K, Machiah K, Ushanandini S, Harish Kumar K, Nagaraju S, et al. Antimicrobial properties of a non-toxic glycoprotein (WSG) from Withania somnifera (Ashwagandha) J Basic Microbiol. 2006;46:365\u2013374. doi: 10.1002/jobm.200510108.", "ArticleIdList": ["10.1002/jobm.200510108", "17009292"]}, {"Citation": "Pawar P, Gilda S, Sharma S, Jagtap S, Paradkar A, et al. Rectal gel application of Withania somnifera root extract expounds anti-inflammatory and muco-restorative activity in TNBS-induced inflammatory bowel disease. BMC Complement Altern Med. 2011;11:34. doi: 10.1186/1472-6882-11-34.", "ArticleIdList": ["10.1186/1472-6882-11-34", "PMC3103490", "21527003"]}, {"Citation": "Minhas U, Minz R, Bhatnagar A. Prophylactic effect of Withania somnifera on inflammation in a non-autoimmune prone murine model of lupus. Drug Discov Ther. 2011;5:195\u2013201. doi: 10.5582/ddt.2011.v5.4.195.", "ArticleIdList": ["10.5582/ddt.2011.v5.4.195", "22466301"]}, {"Citation": "Minhas U, Minz R, Das P, Bhatnagar A. Therapeutic effect of Withania somnifera on pristane-induced model of SLE. Inflammopharmacology. 2012;20:195\u2013205. doi: 10.1007/s10787-011-0102-8.", "ArticleIdList": ["10.1007/s10787-011-0102-8", "22160928"]}, {"Citation": "Ku SK, Han MS, Bae JS. Withaferin A is an inhibitor of endothelial protein C receptor shedding in vitro and in vivo. Food Chem Toxicol. 2014;68:23\u201329. doi: 10.1016/j.fct.2014.03.009.", "ArticleIdList": ["10.1016/j.fct.2014.03.009", "24632454"]}, {"Citation": "Lee W, Kim TH, Ku SK, Min KJ, Lee HS, et al. Barrier protective effects of withaferin A in HMGB1-induced inflammatory responses in both cellular and animal models. Toxicol Appl Pharmacol. 2012;262:91\u201398. doi: 10.1016/j.taap.2012.04.025.", "ArticleIdList": ["10.1016/j.taap.2012.04.025", "22561332"]}, {"Citation": "Kaileh M, Vanden Berghe W, Heyerick A, Horion J, Piette J, et al. Withaferin a strongly elicits IkappaB kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity. J Biol Chem. 2007;282:4253\u20134264. doi: 10.1074/jbc.M606728200.", "ArticleIdList": ["10.1074/jbc.M606728200", "17150968"]}, {"Citation": "Oh JH, Kwon TK. Withaferin A inhibits tumor necrosis factor-alpha-induced expression of cell adhesion molecules by inactivation of Akt and NF-kappaB in human pulmonary epithelial cells. Int Immunopharmacol. 2009;9:614\u2013619. doi: 10.1016/j.intimp.2009.02.002.", "ArticleIdList": ["10.1016/j.intimp.2009.02.002", "19236958"]}, {"Citation": "Heyninck K, Lahtela-Kakkonen M, Van der Veken P, Haegeman G, Vanden Berghe W. Withaferin A inhibits NF-kappaB activation by targeting cysteine 179 in IKKbeta. Biochem Pharmacol. 2014;91:501\u2013509. doi: 10.1016/j.bcp.2014.08.004.", "ArticleIdList": ["10.1016/j.bcp.2014.08.004", "25159986"]}, {"Citation": "Maitra R, Porter MA, Huang S, Gilmour BP. Inhibition of NFkappaB by the natural product Withaferin A in cellular models of Cystic Fibrosis inflammation. J Inflamm (Lond) 2009;6:15. doi: 10.1186/1476-9255-6-15.", "ArticleIdList": ["10.1186/1476-9255-6-15", "PMC2689213", "19439083"]}, {"Citation": "Sumantran VN, Kulkarni A, Boddul S, Chinchwade T, Koppikar SJ, et al. Chondroprotective potential of root extracts of Withania somnifera in osteoarthritis. J Biosci. 2007;32:299\u2013307. doi: 10.1007/s12038-007-0030-3.", "ArticleIdList": ["10.1007/s12038-007-0030-3", "17435322"]}, {"Citation": "Sumantran VN, Chandwaskar R, Joshi AK, Boddul S, Patwardhan B, et al. The relationship between chondroprotective and antiinflammatory effects of Withania somnifera root and glucosamine sulphate on human osteoarthritic cartilage in vitro. Phytother Res. 2008;22:1342\u20131348. doi: 10.1002/ptr.2498.", "ArticleIdList": ["10.1002/ptr.2498", "18697233"]}, {"Citation": "Singh D, Aggarwal A, Maurya R, Naik S. Withania somnifera inhibits NF-kappaB and AP-1 transcription factors in human peripheral blood and synovial fluid mononuclear cells. Phytother Res. 2007;21:905\u2013913. doi: 10.1002/ptr.2180.", "ArticleIdList": ["10.1002/ptr.2180", "17562568"]}, {"Citation": "Rasool M, Varalakshmi P. Protective effect of Withania somnifera root powder in relation to lipid peroxidation, antioxidant status, glycoproteins and bone collagen on adjuvant-induced arthritis in rats. Fundam Clin Pharmacol. 2007;21:157\u2013164. doi: 10.1111/j.1472-8206.2006.00461.x.", "ArticleIdList": ["10.1111/j.1472-8206.2006.00461.x", "17391288"]}, {"Citation": "Khan MA, Subramaneyaan M, Arora VK, Banerjee BD, Ahmed RS. Effect of Withania somnifera (Ashwagandha) root extract on amelioration of oxidative stress and autoantibodies production in collagen-induced arthritic rats. J Complement Integr Med. 2015;12:117\u2013125. doi: 10.1515/jcim-2014-0075.", "ArticleIdList": ["10.1515/jcim-2014-0075", "25803089"]}, {"Citation": "Gupta A, Singh S. Evaluation of anti-inflammatory effect of Withania somnifera root on collagen-induced arthritis in rats. Pharm Biol. 2014;52:308\u2013320. doi: 10.3109/13880209.2013.835325.", "ArticleIdList": ["10.3109/13880209.2013.835325", "24188460"]}, {"Citation": "Dey D, Chaskar S, Athavale N, Chitre D. Inhibition of LPS-induced TNF-alpha and NO production in mouse macrophage and inflammatory response in rat animal models by a novel Ayurvedic formulation, BV-9238. Phytother Res. 2014;28:1479\u20131485. doi: 10.1002/ptr.5151.", "ArticleIdList": ["10.1002/ptr.5151", "24706581"]}, {"Citation": "Ganesan K, Sehgal PK, Mandal AB, Sayeed S. Protective effect of Withania somnifera and Cardiospermum halicacabum extracts against collagenolytic degradation of collagen. Appl Biochem Biotechnol. 2011;165:1075\u20131091. doi: 10.1007/s12010-011-9326-8.", "ArticleIdList": ["10.1007/s12010-011-9326-8", "21789568"]}, {"Citation": "Kim JH, Kim SJ. Overexpression of microRNA-25 by withaferin A induces cyclooxygenase-2 expression in rabbit articular chondrocytes. J Pharmacol Sci. 2014;125:83\u201390. doi: 10.1254/jphs.13232FP.", "ArticleIdList": ["10.1254/jphs.13232FP", "24748433"]}, {"Citation": "Yu SM, Kim SJ. Production of reactive oxygen species by withaferin A causes loss of type collagen expression and COX-2 expression through the PI3\u00a0K/Akt, p38, and JNK pathways in rabbit articular chondrocytes. Exp Cell Res. 2013;319:2822\u20132834. doi: 10.1016/j.yexcr.2013.08.026.", "ArticleIdList": ["10.1016/j.yexcr.2013.08.026", "24016823"]}, {"Citation": "Yu SM, Kim SJ. Withaferin A-caused production of intracellular reactive oxygen species modulates apoptosis via PI3K/Akt and JNKinase in rabbit articular chondrocytes. J Korean Med Sci. 2014;29:1042\u20131053. doi: 10.3346/jkms.2014.29.8.1042.", "ArticleIdList": ["10.3346/jkms.2014.29.8.1042", "PMC4129194", "25120312"]}, {"Citation": "Vaishnavi K, Saxena N, Shah N, Singh R, Manjunath K, et al. Differential activities of the two closely related withanolides, Withaferin A and Withanone: bioinformatics and experimental evidences. PLoS One. 2012;7:e44419. doi: 10.1371/journal.pone.0044419.", "ArticleIdList": ["10.1371/journal.pone.0044419", "PMC3433425", "22973447"]}, {"Citation": "Widodo N, Takagi Y, Shrestha BG, Ishii T, Kaul SC, et al. Selective killing of cancer cells by leaf extract of Ashwagandha: components, activity and pathway analyses. Cancer Lett. 2008;262:37\u201347. doi: 10.1016/j.canlet.2007.11.037.", "ArticleIdList": ["10.1016/j.canlet.2007.11.037", "18191020"]}, {"Citation": "Mayola E, Gallerne C, Esposti DD, Martel C, Pervaiz S, et al. Withaferin A induces apoptosis in human melanoma cells through generation of reactive oxygen species and down-regulation of Bcl-2. Apoptosis. 2011;16:1014\u20131027. doi: 10.1007/s10495-011-0625-x.", "ArticleIdList": ["10.1007/s10495-011-0625-x", "21710254"]}, {"Citation": "Malik F, Kumar A, Bhushan S, Khan S, Bhatia A, et al. Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine. Apoptosis. 2007;12:2115\u20132133. doi: 10.1007/s10495-007-0129-x.", "ArticleIdList": ["10.1007/s10495-007-0129-x", "17874299"]}, {"Citation": "Yang ES, Choi MJ, Kim JH, Choi KS, Kwon TK. Combination of withaferin A and X-ray irradiation enhances apoptosis in U937 cells. Toxicol In Vitro. 2011;25:1803\u20131810. doi: 10.1016/j.tiv.2011.09.016.", "ArticleIdList": ["10.1016/j.tiv.2011.09.016", "21964475"]}, {"Citation": "Hahm ER, Lee J, Singh SV. Role of mitogen-activated protein kinases and Mcl-1 in apoptosis induction by withaferin A in human breast cancer cells. Mol Carcinog. 2014;53:907\u2013916. doi: 10.1002/mc.22050.", "ArticleIdList": ["10.1002/mc.22050", "PMC3859703", "24019090"]}, {"Citation": "Yang ES, Choi MJ, Kim JH, Choi KS, Kwon TK. Withaferin A enhances radiation-induced apoptosis in Caki cells through induction of reactive oxygen species, Bcl-2 downregulation and Akt inhibition. Chem Biol Interact. 2011;190:9\u201315. doi: 10.1016/j.cbi.2011.01.015.", "ArticleIdList": ["10.1016/j.cbi.2011.01.015", "21256832"]}, {"Citation": "Choi MJ, Park EJ, Min KJ, Park JW, Kwon TK. Endoplasmic reticulum stress mediates withaferin A-induced apoptosis in human renal carcinoma cells. Toxicol In Vitro. 2011;25:692\u2013698. doi: 10.1016/j.tiv.2011.01.010.", "ArticleIdList": ["10.1016/j.tiv.2011.01.010", "21266191"]}, {"Citation": "Kim SH, Singh SV. Mammary cancer chemoprevention by withaferin A is accompanied by in vivo suppression of self-renewal of cancer stem cells. Cancer Prev Res (Phila) 2014;7:738\u2013747. doi: 10.1158/1940-6207.CAPR-13-0445.", "ArticleIdList": ["10.1158/1940-6207.CAPR-13-0445", "PMC4083822", "24824039"]}, {"Citation": "Hahm ER, Lee J, Kim SH, Sehrawat A, Arlotti JA, et al. Metabolic alterations in mammary cancer prevention by withaferin A in a clinically relevant mouse model. J Natl Cancer Inst. 2013;105:1111\u20131122. doi: 10.1093/jnci/djt153.", "ArticleIdList": ["10.1093/jnci/djt153", "PMC3735460", "23821767"]}, {"Citation": "Hahm ER, Moura MB, Kelley EE, Van Houten B, Shiva S, et al. Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species. PLoS One. 2011;6:e23354. doi: 10.1371/journal.pone.0023354.", "ArticleIdList": ["10.1371/journal.pone.0023354", "PMC3154436", "21853114"]}, {"Citation": "Hahm ER, Singh SV. Autophagy fails to alter withaferin A-mediated lethality in human breast cancer cells. Curr Cancer Drug Targets. 2013;13:640\u2013650. doi: 10.2174/15680096113139990039.", "ArticleIdList": ["10.2174/15680096113139990039", "PMC3723758", "23607597"]}, {"Citation": "Lee J, Sehrawat A, Singh SV. Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells. Breast Cancer Res Treat. 2012;136:45\u201356. doi: 10.1007/s10549-012-2239-6.", "ArticleIdList": ["10.1007/s10549-012-2239-6", "PMC3474857", "22965833"]}, {"Citation": "Stan SD, Zeng Y, Singh SV. Ayurvedic medicine constituent withaferin a causes G2 and M phase cell cycle arrest in human breast cancer cells. Nutr Cancer. 2008;60(Suppl 1):51\u201360. doi: 10.1080/01635580802381477.", "ArticleIdList": ["10.1080/01635580802381477", "PMC2597540", "19003581"]}, {"Citation": "Nagalingam A, Kuppusamy P, Singh SV, Sharma D, Saxena NK. Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer. Cancer Res. 2014;74:2617\u20132629. doi: 10.1158/0008-5472.CAN-13-2081.", "ArticleIdList": ["10.1158/0008-5472.CAN-13-2081", "PMC4009451", "24732433"]}, {"Citation": "Lee JH, Kim JE, Jang YJ, Lee CC, Lim TG, et al. Dehydroglyasperin C suppresses TPA-induced cell transformation through direct inhibition of MKK4 and PI3K. Mol Carcinog. 2015", "ArticleIdList": ["25787879"]}, {"Citation": "Antony ML, Lee J, Hahm ER, Kim SH, Marcus AI, et al. Growth arrest by the antitumor steroidal lactone withaferin A in human breast cancer cells is associated with down-regulation and covalent binding at cysteine 303 of beta-tubulin. J Biol Chem. 2014;289:1852\u20131865. doi: 10.1074/jbc.M113.496844.", "ArticleIdList": ["10.1074/jbc.M113.496844", "PMC3894360", "24297176"]}, {"Citation": "Mathur R, Gupta SK, Singh N, Mathur S, Kochupillai V, et al. Evaluation of the effect of Withania somnifera root extracts on cell cycle and angiogenesis. J Ethnopharmacol. 2006;105:336\u2013341. doi: 10.1016/j.jep.2005.11.020.", "ArticleIdList": ["10.1016/j.jep.2005.11.020", "16412596"]}, {"Citation": "Mohan R, Hammers HJ, Bargagna-Mohan P, Zhan XH, Herbstritt CJ, et al. Withaferin A is a potent inhibitor of angiogenesis. Angiogenesis. 2004;7:115\u2013122. doi: 10.1007/s10456-004-1026-3.", "ArticleIdList": ["10.1007/s10456-004-1026-3", "15516832"]}, {"Citation": "Yang H, Wang Y, Cheryan VT, Wu W, Cui CQ, et al. Withaferin A inhibits the proteasome activity in mesothelioma in vitro and in vivo. PLoS One. 2012;7:e41214. doi: 10.1371/journal.pone.0041214.", "ArticleIdList": ["10.1371/journal.pone.0041214", "PMC3422308", "22912669"]}, {"Citation": "Um HJ, Min KJ, Kim DE, Kwon TK. Withaferin A inhibits JAK/STAT3 signaling and induces apoptosis of human renal carcinoma Caki cells. Biochem Biophys Res Commun. 2012;427:24\u201329. doi: 10.1016/j.bbrc.2012.08.133.", "ArticleIdList": ["10.1016/j.bbrc.2012.08.133", "22982675"]}, {"Citation": "Das PK, Malhotra CL, Prasad K. Cardiotonic activity of Ashwagandhine and Ashwagandhinine, two alkaloids from Withania ashwagandha, Kaul. Arch Int Pharmacodyn Ther. 1964;150:356\u2013362.", "ArticleIdList": ["14203112"]}, {"Citation": "Ojha SK, Arya DS. Withania somnifera Dunal (Ashwagandha): a promising remedy for cardiovascular diseases. World J Med Sci. 2009;4:156\u2013158."}, {"Citation": "Prince PSM, Suman S, Devika PT, Vaithianathan M. Cardioprotective effect of \u2018Marutham\u2019a polyherbal formulation on isoproterenol induced myocardial infarction in Wistar rats. Fitoterapia. 2008;79:433\u2013438. doi: 10.1016/j.fitote.2008.01.009.", "ArticleIdList": ["10.1016/j.fitote.2008.01.009", "18538507"]}, {"Citation": "Thirunavukkarasu M, Penumathsa S, Juhasz B, Zhan L, Bagchi M, et al. Enhanced cardiovascular function and energy level by a novel chromium (III)-supplement. BioFactors. 2006;27:53\u201367. doi: 10.1002/biof.5520270106.", "ArticleIdList": ["10.1002/biof.5520270106", "17012764"]}, {"Citation": "Mohan IK, Kumar KV, Naidu MU, Khan M, Sundaram C. Protective effect of CardiPro against doxorubicin-induced cardiotoxicity in mice. Phytomedicine. 2006;13:222\u2013229. doi: 10.1016/j.phymed.2004.09.003.", "ArticleIdList": ["10.1016/j.phymed.2004.09.003", "16492523"]}, {"Citation": "Reuland DJ, Khademi S, Castle CJ, Irwin DC, McCord JM, et al. Upregulation of phase II enzymes through phytochemical activation of Nrf2 protects cardiomyocytes against oxidant stress. Free Radic Biol Med. 2013;56:102\u2013111. doi: 10.1016/j.freeradbiomed.2012.11.016.", "ArticleIdList": ["10.1016/j.freeradbiomed.2012.11.016", "23201694"]}, {"Citation": "Aphale AA, Chhibba AD, Kumbhakarna NR, Mateenuddin M, Dahat SH. Subacute toxicity study of the combination of ginseng (Panax ginseng) and ashwagandha (Withania somnifera) in rats: a safety assessment. Indian J Physiol Pharmacol. 1998;42:299\u2013302.", "ArticleIdList": ["10225062"]}, {"Citation": "Mohanty IR, Arya DS, Gupta SK. Withania somnifera provides cardioprotection and attenuates ischemia-reperfusion induced apoptosis. Clin Nutr. 2008;27:635\u2013642. doi: 10.1016/j.clnu.2008.05.006.", "ArticleIdList": ["10.1016/j.clnu.2008.05.006", "18620784"]}, {"Citation": "Gupta SK, Mohanty I, Talwar KK, Dinda A, Joshi S, et al. Cardioprotection from ischemia and reperfusion injury by Withania somnifera: a hemodynamic, biochemical and histopathological assessment. Mol Cell Biochem. 2004;260:39\u201347. doi: 10.1023/B:MCBI.0000026051.16803.03.", "ArticleIdList": ["10.1023/B:MCBI.0000026051.16803.03", "15228084"]}, {"Citation": "Mohanty I, Arya DS, Dinda A, Talwar KK, Joshi S, et al. Mechanisms of cardioprotective effect of Withania somnifera in experimentally induced myocardial infarction. Basic Clin Pharmacol Toxicol. 2004;94:184\u2013190. doi: 10.1111/j.1742-7843.2004.pto940405.x.", "ArticleIdList": ["10.1111/j.1742-7843.2004.pto940405.x", "15078343"]}, {"Citation": "Ashour OM, Abdel-Naim AB, Abdallah HM, Nagy AA, Mohamadin AM, et al. Evaluation of the potential cardioprotective activity of some Saudi plants against doxorubicin toxicity. Z Naturforsch C. 2012;67:297\u2013307. doi: 10.5560/ZNC.2012.67c0297.", "ArticleIdList": ["10.5560/ZNC.2012.67c0297", "22888535"]}, {"Citation": "Hamza A, Amin A, Daoud S. The protective effect of a purified extract of Withania somnifera against doxorubicin-induced cardiac toxicity in rats. Cell Biol Toxicol. 2008;24:63\u201373. doi: 10.1007/s10565-007-9016-z.", "ArticleIdList": ["10.1007/s10565-007-9016-z", "17520333"]}, {"Citation": "Gauttam VK, Kalia AN. Development of polyherbal antidiabetic formulation encapsulated in the phospholipids vesicle system. J Adv Pharm Technol Res. 2013;4:108\u2013117. doi: 10.4103/2231-4040.111527.", "ArticleIdList": ["10.4103/2231-4040.111527", "PMC3696222", "23833751"]}, {"Citation": "Mutalik S, Chetana M, Sulochana B, Devi PU, Udupa N. Effect of Dianex, a herbal formulation on experimentally induced diabetes mellitus. Phytother Res. 2005;19:409\u2013415. doi: 10.1002/ptr.1570.", "ArticleIdList": ["10.1002/ptr.1570", "16106394"]}, {"Citation": "Bhattacharya SK, Satyan KS, Chakrabarti A. Effect of Trasina, an Ayurvedic herbal formulation, on pancreatic islet superoxide dismutase activity in hyperglycaemic rats. Indian J Exp Biol. 1997;35:297\u2013299.", "ArticleIdList": ["9332177"]}, {"Citation": "Andallu B, Radhika B. Hypoglycemic, diuretic and hypocholesterolemic effect of winter cherry (Withania somnifera, Dunal) root. Indian J Exp Biol. 2000;38:607\u2013609.", "ArticleIdList": ["11116534"]}, {"Citation": "Anwer T, Sharma M, Pillai KK, Iqbal M. Effect of Withania somnifera on insulin sensitivity in non-insulin-dependent diabetes mellitus rats. Basic Clin Pharmacol Toxicol. 2008;102:498\u2013503. doi: 10.1111/j.1742-7843.2008.00223.x.", "ArticleIdList": ["10.1111/j.1742-7843.2008.00223.x", "18346053"]}, {"Citation": "Gorelick J, Rosenberg R, Smotrich A, Hanus L, Bernstein N (2015) Hypoglycemic activity of withanolides and elicitated Withania somnifera. Phytochemistry", "ArticleIdList": ["25796090"]}, {"Citation": "Udayakumar R, Kasthurirengan S, Mariashibu TS, Rajesh M, Anbazhagan VR, Kim SC, Ganapathi A, Choi CW. Hypoglycaemic and hypolipidaemic effects of Withania somnifera root and leaf extracts on alloxan-induced diabetic rats. Int J Mol Sci. 2009;10(5):2367\u20132382. doi: 10.3390/ijms10052367.", "ArticleIdList": ["10.3390/ijms10052367", "PMC2695282", "19564954"]}, {"Citation": "Udayakumar R, Kasthurirengan S, Vasudevan A, Mariashibu TS, Rayan JJ, et al. Antioxidant effect of dietary supplement Withania somnifera L. reduce blood glucose levels in alloxan-induced diabetic rats. Plant Foods Hum Nutr. 2010;65:91\u201398. doi: 10.1007/s11130-009-0146-8.", "ArticleIdList": ["10.1007/s11130-009-0146-8", "20186490"]}, {"Citation": "SoRelle JA, Itoh T, Peng H, Kanak MA, Sugimoto K, et al. Withaferin A inhibits pro-inflammatory cytokine-induced damage to islets in culture and following transplantation. Diabetologia. 2013;56:814\u2013824. doi: 10.1007/s00125-012-2813-9.", "ArticleIdList": ["10.1007/s00125-012-2813-9", "23318585"]}, {"Citation": "Babu PV, Gokulakrishnan A, Dhandayuthabani R, Ameethkhan D, Kumar CV, et al. Protective effect of Withania somnifera (Solanaceae) on collagen glycation and cross-linking. Comp Biochem Physiol B Biochem Mol Biol. 2007;147:308\u2013313. doi: 10.1016/j.cbpb.2007.01.011.", "ArticleIdList": ["10.1016/j.cbpb.2007.01.011", "17329138"]}, {"Citation": "Bhattacharya SK, Kumar A, Ghosal S. Effects of glycowithanolides from Withania somnifera on an animal model of Alzheimer\u2019s disease and perturbed central cholinergic markers of cognition in rats. Phytother Res. 1995;9:110\u2013113. doi: 10.1002/ptr.2650090206.", "ArticleIdList": ["10.1002/ptr.2650090206"]}, {"Citation": "Kaur P, Mathur S, Sharma M, Tiwari M, Srivastava KK, et al. A biologically active constituent of Withania somnifera (ashwagandha) with antistress activity. Indian J Clin Biochem. 2001;16:195\u2013198. doi: 10.1007/BF02864860.", "ArticleIdList": ["10.1007/BF02864860", "PMC3453638", "23105317"]}, {"Citation": "Singh B, Saxena AK, Chandan BK, Gupta DK, Bhutani KK, et al. Adaptogenic activity of a novel, withanolide-free aqueous fraction from the roots of Withania somnifera Dun. Phytother Res. 2001;15:311\u2013318. doi: 10.1002/ptr.858.", "ArticleIdList": ["10.1002/ptr.858", "11406854"]}, {"Citation": "Khan B, Ahmad SF, Bani S, Kaul A, Suri KA, et al. Augmentation and proliferation of T lymphocytes and Th-1 cytokines by Withania somnifera in stressed mice. Int Immunopharmacol. 2006;6:1394\u20131403. doi: 10.1016/j.intimp.2006.04.001.", "ArticleIdList": ["10.1016/j.intimp.2006.04.001", "16846833"]}, {"Citation": "Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012;34:255\u2013262. doi: 10.4103/0253-7176.106022.", "ArticleIdList": ["10.4103/0253-7176.106022", "PMC3573577", "23439798"]}, {"Citation": "Bhattacharya A, Muruganandam AV, Kumar V, Bhattacharya SK. Effect of poly herbal formulation, EuMil, on neurochemical perturbations induced by chronic stress. Indian J Exp Biol. 2002;40:1161\u20131163.", "ArticleIdList": ["12693697"]}, {"Citation": "Muruganandam AV, Kumar V, Bhattacharya SK. Effect of poly herbal formulation, EuMil, on chronic stress-induced homeostatic perturbations in rats. Indian J Exp Biol. 2002;40:1151\u20131160.", "ArticleIdList": ["12693696"]}, {"Citation": "Ramanathan M, Balaji B, Justin A. Behavioural and neurochemical evaluation of Perment an herbal formulation in chronic unpredictable mild stress induced depressive model. Indian J Exp Biol. 2011;49:269\u2013275.", "ArticleIdList": ["21614890"]}, {"Citation": "Bhattacharya SK, Bhattacharya A, Sairam K, Ghosal S. Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: an experimental study. Phytomedicine. 2000;7:463\u2013469. doi: 10.1016/S0944-7113(00)80030-6.", "ArticleIdList": ["10.1016/S0944-7113(00)80030-6", "11194174"]}, {"Citation": "Bhattacharya A, Ghosal S, Bhattacharya SK. Anti-oxidant effect of Withania somnifera glycowithanolides in chronic footshock stress-induced perturbations of oxidative free radical scavenging enzymes and lipid peroxidation in rat frontal cortex and striatum. J Ethnopharmacol. 2001;74:1\u20136. doi: 10.1016/S0378-8741(00)00309-3.", "ArticleIdList": ["10.1016/S0378-8741(00)00309-3", "11137343"]}, {"Citation": "Durg S, Dhadde SB, Vandal R, Shivakumar BS, Charan CS (2015) Withania somnifera (Ashwagandha) in neurobehavioural disorders induced by brain oxidative stress in rodents: a systematic review and meta-analysis. J Pharm Pharmacol", "ArticleIdList": ["25828061"]}, {"Citation": "Wollen KA. Alzheimer\u2019s disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners. Altern Med Rev. 2010;15(3):223\u2013244.", "ArticleIdList": ["21155625"]}, {"Citation": "Singh RH, Narsimhamurthy K, Singh G. Neuronutrient impact of Ayurvedic Rasayana therapy in brain aging. Biogerontology. 2008;9:369\u2013374. doi: 10.1007/s10522-008-9185-z.", "ArticleIdList": ["10.1007/s10522-008-9185-z", "18931935"]}, {"Citation": "Kuboyama T, Tohda C, Komatsu K. Effects of Ashwagandha (roots of Withania somnifera) on neurodegenerative diseases. Biol Pharm Bull. 2014;37:892\u2013897. doi: 10.1248/bpb.b14-00022.", "ArticleIdList": ["10.1248/bpb.b14-00022", "24882401"]}, {"Citation": "Konar A, Shah N, Singh R, Saxena N, Kaul SC, et al. Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells. PLoS One. 2011;6:e27265. doi: 10.1371/journal.pone.0027265.", "ArticleIdList": ["10.1371/journal.pone.0027265", "PMC3214041", "22096544"]}, {"Citation": "Kumar P, Singh R, Nazmi A, Lakhanpal D, Kataria H, et al. Glioprotective effects of Ashwagandha leaf extract against lead induced toxicity. Biomed Res Int. 2014;2014:182029.", "ArticleIdList": ["PMC4058459", "24987671"]}, {"Citation": "Bhattacharya SK, Satyan KS. Experimental methods for evaluation of psychotropic agents in rodents: I-Anti-anxiety agents. Indian J Exp Biol. 1997;35:565\u2013575.", "ArticleIdList": ["9357158"]}, {"Citation": "Parihar MS, Hemnani T. Alzheimer\u2019s disease pathogenesis and therapeutic interventions. J Clin Neurosci. 2004;11:456\u2013467. doi: 10.1016/j.jocn.2003.12.007.", "ArticleIdList": ["10.1016/j.jocn.2003.12.007", "15177383"]}, {"Citation": "Jain S, Shukla SD, Sharma K, Bhatnagar M. Neuroprotective effects of Withania somnifera Dunn in hippocampal sub-regions of female albino rat. Phytother Res. 2001;15:544\u2013548. doi: 10.1002/ptr.802.", "ArticleIdList": ["10.1002/ptr.802", "11536389"]}, {"Citation": "Zhao J, Nakamura N, Hattori M, Kuboyama T, Tohda C, et al. Withanolide derivatives from the roots of Withania somnifera and their neurite outgrowth activities. Chem Pharm Bull (Tokyo) 2002;50:760\u2013765. doi: 10.1248/cpb.50.760.", "ArticleIdList": ["10.1248/cpb.50.760", "12045329"]}, {"Citation": "Kuboyama T, Tohda C, Zhao J, Nakamura N, Hattori M, et al. Axon- or dendrite-predominant outgrowth induced by constituents from Ashwagandha. NeuroReport. 2002;13:1715\u20131720. doi: 10.1097/00001756-200210070-00005.", "ArticleIdList": ["10.1097/00001756-200210070-00005", "12395110"]}, {"Citation": "Kuboyama T, Tohda C, Komatsu K. Withanoside IV and its active metabolite, sominone, attenuate Abeta(25\u201335)-induced neurodegeneration. Eur J Neurosci. 2006;23:1417\u20131426. doi: 10.1111/j.1460-9568.2006.04664.x.", "ArticleIdList": ["10.1111/j.1460-9568.2006.04664.x", "16553605"]}, {"Citation": "Kataria H, Wadhwa R, Kaul SC, Kaur G. Water extract from the leaves of Withania somnifera protect RA differentiated C6 and IMR-32 cells against glutamate-induced excitotoxicity. PLoS One. 2012;7:e37080. doi: 10.1371/journal.pone.0037080.", "ArticleIdList": ["10.1371/journal.pone.0037080", "PMC3351387", "22606332"]}, {"Citation": "Parihar MS, Hemnani T. Phenolic antioxidants attenuate hippocampal neuronal cell damage against kainic acid induced excitotoxicity. J Biosci. 2003;28:121\u2013128. doi: 10.1007/BF02970142.", "ArticleIdList": ["10.1007/BF02970142", "12682435"]}, {"Citation": "Ahmad M, Saleem S, Ahmad AS, Ansari MA, Yousuf S, et al. Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. Hum Exp Toxicol. 2005;24:137\u2013147. doi: 10.1191/0960327105ht509oa.", "ArticleIdList": ["10.1191/0960327105ht509oa", "15901053"]}, {"Citation": "Sankar SR, Manivasagam T, Krishnamurti A, Ramanathan M. The neuroprotective effect of Withania somnifera root extract in MPTP-intoxicated mice: an analysis of behavioral and biochemical variables. Cell Mol Biol Lett. 2007;12:473\u2013481. doi: 10.2478/s11658-007-0015-0.", "ArticleIdList": ["10.2478/s11658-007-0015-0", "PMC6275882", "17415533"]}, {"Citation": "RajaSankar S, Manivasagam T, Sankar V, Prakash S, Muthusamy R, et al. Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson\u2019s disease model mouse. J Ethnopharmacol. 2009;125:369\u2013373. doi: 10.1016/j.jep.2009.08.003.", "ArticleIdList": ["10.1016/j.jep.2009.08.003", "19666100"]}, {"Citation": "Rajasankar S, Manivasagam T, Surendran S. Ashwagandha leaf extract: a potential agent in treating oxidative damage and physiological abnormalities seen in a mouse model of Parkinson\u2019s disease. Neurosci Lett. 2009;454:11\u201315. doi: 10.1016/j.neulet.2009.02.044.", "ArticleIdList": ["10.1016/j.neulet.2009.02.044", "19429045"]}, {"Citation": "Manjunath MJ, Muralidhara Standardized extract of Withania somnifera (Ashwagandha) markedly offsets rotenone-induced locomotor deficits, oxidative impairments and neurotoxicity in Drosophila melanogaster . J Food Sci Technol. 2015;52:1971\u20131981. doi: 10.1007/s13197-013-1219-0.", "ArticleIdList": ["10.1007/s13197-013-1219-0", "PMC4375188", "25829577"]}, {"Citation": "Manjunath MJ, Muralidhara Effect of Withania somnifera supplementation on rotenone-induced oxidative damage in cerebellum and striatum of the male mice brain. Cent Nerv Syst Agents Med Chem. 2013;13:43\u201356. doi: 10.2174/1871524911313010007.", "ArticleIdList": ["10.2174/1871524911313010007", "23092410"]}, {"Citation": "Prakash J, Chouhan S, Yadav SK, Westfall S, Rai SN, et al. Withania somnifera alleviates parkinsonian phenotypes by inhibiting apoptotic pathways in dopaminergic neurons. Neurochem Res. 2014;39:2527\u20132536. doi: 10.1007/s11064-014-1443-7.", "ArticleIdList": ["10.1007/s11064-014-1443-7", "25403619"]}, {"Citation": "Prakash J, Yadav SK, Chouhan S, Singh SP. Neuroprotective role of Withania somnifera root extract in maneb-paraquat induced mouse model of parkinsonism. Neurochem Res. 2013;38:972\u2013980. doi: 10.1007/s11064-013-1005-4.", "ArticleIdList": ["10.1007/s11064-013-1005-4", "23430469"]}, {"Citation": "Pingali U, Pilli R, Fatima N. Effect of standardized aqueous extract of Withania somnifera on tests of cognitive and psychomotor performance in healthy human participants. Pharmacognosy Res. 2014;6:12\u201318. doi: 10.4103/0974-8490.122912.", "ArticleIdList": ["10.4103/0974-8490.122912", "PMC3897003", "24497737"]}, {"Citation": "Sehgal N, Gupta A, Valli RK, Joshi SD, Mills JT, et al. Withania somnifera reverses Alzheimer\u2019s disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proc Natl Acad Sci USA. 2012;109:3510\u20133515. doi: 10.1073/pnas.1112209109.", "ArticleIdList": ["10.1073/pnas.1112209109", "PMC3295277", "22308347"]}, {"Citation": "Jayaprakasam B, Padmanabhan K, Nair MG. Withanamides in Withania somnifera fruit protect PC-12 cells from beta-amyloid responsible for Alzheimer\u2019s disease. Phytother Res. 2010;24:859\u2013863.", "ArticleIdList": ["19957250"]}, {"Citation": "Grover A, Shandilya A, Agrawal V, Bisaria VS, Sundar D. Computational evidence to inhibition of human acetyl cholinesterase by withanolide a for Alzheimer treatment. J Biomol Struct Dyn. 2012;29:651\u2013662. doi: 10.1080/07391102.2012.10507408.", "ArticleIdList": ["10.1080/07391102.2012.10507408", "22208270"]}, {"Citation": "Yadav CS, Kumar V, Suke SG, Ahmed RS, Mediratta PK, et al. Propoxur-induced acetylcholine esterase inhibition and impairment of cognitive function: attenuation by Withania somnifera . Indian J Biochem Biophys. 2010;47:117\u2013120.", "ArticleIdList": ["20521626"]}, {"Citation": "Ahmed ME, Javed H, Khan MM, Vaibhav K, Ahmad A, et al. Attenuation of oxidative damage-associated cognitive decline by Withania somnifera in rat model of streptozotocin-induced cognitive impairment. Protoplasma. 2013;250:1067\u20131078. doi: 10.1007/s00709-013-0482-2.", "ArticleIdList": ["10.1007/s00709-013-0482-2", "23340606"]}, {"Citation": "Kurapati KR, Atluri VS, Samikkannu T, Nair MP. Ashwagandha (Withania somnifera) reverses beta-amyloid1-42 induced toxicity in human neuronal cells: implications in HIV-associated neurocognitive disorders (HAND) PLoS One. 2013;8:e77624. doi: 10.1371/journal.pone.0077624.", "ArticleIdList": ["10.1371/journal.pone.0077624", "PMC3797707", "24147038"]}, {"Citation": "Kurapati KR, Samikkannu T, Atluri VS, Kaftanovskaya E, Yndart A, et al. beta-Amyloid1-42, HIV-1Ba-L (clade B) infection and drugs of abuse induced degeneration in human neuronal cells and protective effects of ashwagandha (Withania somnifera) and its constituent Withanolide A. PLoS One. 2014;9:e112818. doi: 10.1371/journal.pone.0112818.", "ArticleIdList": ["10.1371/journal.pone.0112818", "PMC4240587", "25415340"]}, {"Citation": "Kumar S, Seal CJ, Howes MJ, Kite GC, Okello EJ. In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and beta-amyloid(1-42)-induced cytotoxicity in differentiated PC12 cells. Phytother Res. 2010;24:1567\u20131574. doi: 10.1002/ptr.3261.", "ArticleIdList": ["10.1002/ptr.3261", "20680931"]}, {"Citation": "Chaudhary G, Sharma U, Jagannathan NR, Gupta YK. Evaluation of Withania somnifera in a middle cerebral artery occlusion model of stroke in rats. Clin Exp Pharmacol Physiol. 2003;30:399\u2013404. doi: 10.1046/j.1440-1681.2003.03849.x.", "ArticleIdList": ["10.1046/j.1440-1681.2003.03849.x", "12859433"]}, {"Citation": "Raghavan A, Shah ZA. Withania somnifera improves ischemic stroke outcomes by attenuating PARP1-AIF-mediated caspase-independent Apoptosis . Mol Neurobiol. 2014", "ArticleIdList": ["25294638"]}, {"Citation": "Raghavan A, Shah ZA. Withania somnifera: a pre-clinical study on neuroregenerative therapy for stroke. Neural Regen Res. 2015;10:183\u2013185. doi: 10.4103/1673-5374.152362.", "ArticleIdList": ["10.4103/1673-5374.152362", "PMC4392656", "25883607"]}, {"Citation": "Baitharu I, Jain V, Deep SN, Hota KB, Hota SK, et al. Withania somnifera root extract ameliorates hypobaric hypoxia induced memory impairment in rats. J Ethnopharmacol. 2013;145:431\u2013441. doi: 10.1016/j.jep.2012.10.063.", "ArticleIdList": ["10.1016/j.jep.2012.10.063", "23211660"]}, {"Citation": "Baitharu I, Jain V, Deep SN, Shroff S, Sahu JK, et al. Withanolide A prevents neurodegeneration by modulating hippocampal glutathione biosynthesis during hypoxia. PLoS One. 2014;9:e105311. doi: 10.1371/journal.pone.0105311.", "ArticleIdList": ["10.1371/journal.pone.0105311", "PMC4195593", "25310001"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "6", "Day": "2"}, {"Year": "2015", "Month": "8", "Day": "3"}, {"Year": "2015", "Month": "7", "Day": "28"}, {"Year": "2015", "Month": "8", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "8", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "4", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "8", "Day": "26"}], "PublicationStatus": "ppublish", "ArticleIdList": ["26306935", "PMC11113996", "10.1007/s00018-015-2012-1", "10.1007/s00018-015-2012-1"]}}], "PubmedBookArticle": []}